Corynebacterium amycolatum, a normal inhabitant of human skin, is a Gram-positive, non-sporeforming, mycolic acid-free, aerobic or facultative anaerobic bacillus. Since its description in 1988, it has only rarely been associated with infective endocarditis. This paper describes a case of infective endocarditis successfully treated by combination therapy with daptomycin and rifampicin. To the best of our knowledge, this is the first case report of C. amycolatum endocarditis from the USA successfully treated with these agents.
Case reportThe patient was an 84-year-old female resident in a longterm care facility with end-stage renal disease requiring haemodialysis three times a week via a left subclavian haemodialysis catheter, and with atherosclerotic heart disease, hypertension and congestive heart failure. The patient was referred to our hospital from a dialysis centre with fever and hypotension. On physical examination, her blood pressure was 92/78 mmHg, her temperature was 39.8 u C and a new loud cardiac murmur localized in the mitral area was evident. No peripheral stigmata of endocarditis were present.Initial blood work showed 17 800 leukocytes ml 21 (84 % neutrophils, 16 % lymphocytes), and blood cultures performed at admission resulted in the growth of Gram-positive rods within 24 h in all four bottles. These were later identified as Corynebacterium amycolatum using the API Coryne database 2.0 (bioMérieux). Susceptibility by Etest gave the following MICs (mg ml 21 ): penicillin, 16; ampicillin, 32; erythromycin, 16; levofloxacin, 16; rifampicin, 0.004; daptomycin, 0.19; linezolid, 0.38; and vancomycin, 0.5. Transthoracic echocardiography revealed normal functioning valves, without evidence of vegetation, thrombi or pericardial effusion. Transoesophageal echocardiography on hospital day 2 detected a small mobile echodensity attached to the mitral valve, consistent with a vegetation. Urine and sputum cultures remained negative for bacterial growth.